1. Wertheim J. O, Smith M. D, Smith D. M., Scheffler K, Kosakovsky Pond S. L. Evolutionary origins of human herpes simplex viruses 1 and 2. Mol Biol Evol. 2014 Sep 1;31(9):2356–64.

2. Hutfield D. C. History of herpes genitalis. Br J Vener Dis. 1966 Dec;42(4): 263–8.

3. Moholy-Nagy S. The Architecture of Paul Rudolph. New York: Praeger; 1970:233. http://prudolph.lib.umassd.edu/node/4561.

4. United States Food and Drug Administration. Drugs, devices, and the FDA: part 1: an overview of approval processes for drugs. Available at: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htm. Accessed February 18, 2018.

5. King D. H. History, pharmacokinetics, and pharmacology of acyclovir. J Am Acad Dermatol. 1988;18(1 Pt 2):176–9.

6. Cuatrecasas P. Drug discovery in jeopardy. J Clin Invest. 2006;116(11):2837–2842.

7. Leo J. The new scarlet letter. Time. 1982;120(5). Available at: http://content.time.com/time/subscriber/article/0,33009,1715020,00.html. Accessed January 7, 2018.

8. McInnis D. Herpes: Burroughs Wellcome sees its treatment as a way to cure profit ills. New York Times. June 19, 1983. Available at: https://www.nytimes.com/1983/06/19/business/herpes-burroughs-wellcome-sees-ts-treatment-as-a-way-to-cure-profit-ills.html. Accessed February 14, 2018.

9. McCaffrey K. Drugmakers again boost DTC spending, to $5.6 billion in 2016. MM&M. March 3, 2017. Available at: https://www.mmm-online.com/features/has-tc-in-the-oncology-space-kept-up-with-science/article/747441/. Accessed March 18, 2018.

10. Donohue J. A History of drug advertising: the evolving roles of consumers and consumer protection. Milbank Q. 2006;84(4):659–99.

11. Mogull S. A.. Chronology of direct-to-consumer advertising regulation in the United States. AMWA Journal. 2008;23(3):106–9.